| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |